Informed Consent
24 videos · last 6 months shuffled daily, then older videos newest first
▶
22:39 Sarcoma Exchange 2026: Clinical Trial Basics with Hope Ventricelli of CISCRP
Hope Ventricelli of CISCRP covers the fundamentals — trial phases, informed consent, the protections in place for patients, and what taking part actually involves.
▶
56:20 How AI Is Transforming IRBs and Human Research Protections
Tamiko Eto of HRP Consulting discusses the risks and benefits of AI for IRBs and compliance professionals, from IRB triage and consent drafting to vendor due diligence, on CITI Program's Culture of Compliance podcast.
▶
39:39 Sarepta's Wendy Erler on Patient Communities
Wendy Erler, Senior Vice President of Patient Affairs at Sarepta, discusses informed consent, natural history studies, patient-reported data and how global registries can speed up clinical trials, for the ZTTK SON-Shine Foundation.
▶
7:55 "Clinical Trials 101" by University of Colorado's Dr. Breelyn Wilky (2020)
University of Colorado medical oncologist Dr. Breelyn Wilky introduces clinical trials — the goals and structure of each phase, and what patients should consider before signing on.
▶
4:50 What Does It Mean to Consent to Take Part in a Research Study?
The third of four NIHR films made with people who have learning disabilities and autism, on what it means to consent to a research study. Presented with British Sign Language.
▶
23:43 CTSI Watch and Learn: Providing Informed Consent: The HRP-502 (2026)
University at Buffalo IRB administrator Zachary Chakan walks through informed consent, the HRP-502 consent form template and its parts, and how to present information to potential subjects.
▶
1:00:54 How Cancer Research Becomes Treatment: Trials Explained
An OCRA panel including Roisin O'Cearbhaill, MD, and Alessia Baccarini, PhD, explains how cancer drugs move from laboratory to approval, covering trial phases, consent, safety oversight and eligibility, with an ovarian cancer survivor on joining a trial.
▶
1:25 IRB Process How the Consent Form Is Prepared for Review
Advarra on the editorial review every informed consent form goes through before it reaches its Institutional Review Board.
▶
1:58 Evaluating Informed Consent Disclosures in AI Clinical Trials
Hankun Su of Xiangya Hospital, Central South University presents an analysis of 114 AI clinical trials on ClinicalTrials.gov that found 58% of consent documents did not disclose the AI type or intended use.
▶
36:20 Rethinking Child Assent Practices in Research
Dr. David Coker discusses rethinking child assent in research beyond procedural compliance, including regulatory tensions, inclusion of children with disabilities and the role of IRBs, on CITI Program's On Research podcast.
▶
1:11 Your Rights and Informed Consent in Clinical Trials
The Pulmonary Vascular Research Institute explains informed consent for people with pulmonary hypertension considering a trial, including the right to ask questions, take time to decide and withdraw at any time.
▶
37:09 Pandemic Lessons for Everyday Informed Consent
Lisa Harewood, CCRP, Senior Clinical Trials Regulatory Specialist at the Hope Clinic of Emory Vaccine Center, discusses bringing lessons from the pandemic into the everyday informed consent process, at the SOCRA 2023 Annual Conference.
▶
3:31 Inside the uMotif Platform: Experience Modern eCOA, ePRO and eConsent
uMotif on its eCOA, ePRO and eConsent platform for clinical trials.
▶
5:24 Pragmatic Clinical Trials: The Ethics of Conducting Research in the Real World
Mayo Clinic's Dr. Laszlo Vaszar reviews his Mayo Clinic Proceedings article on the ethics of pragmatic clinical trials, including the new approaches to informed consent they require.
▶
46:58 Decentralized Clinical Trials Forum, Clinical Trials BC
Speakers from LifeLabs, UBC, AbCellera and RealTime discuss home services, digital health, CRO operations and eConsent in decentralized trials at the Clinical Trials BC Symposium 2023.
▶
59:26 Informed Consent and How Your Safety Is a Priority
A Cystic Fibrosis Foundation town hall from the Southeast Research Collaborative explains how safety and privacy are protected in trials and what the informed consent process involves.
▶
1:45 The Clinical Trial Consent and Screening Process
Pfizer outlines the key steps to joining a clinical trial, including the consent and screening process a prospective participant can expect.
▶
1:43 What Is Informed Consent?
The National Institute of Mental Health explains what informed consent means for people taking part in a clinical trial.
▶
3:41 Deciding to Participate in a Clinical Trial
A clinical trial investigator walks through what patients often weigh when deciding whether to join a clinical trial, from safety measures to informed consent, and why asking questions throughout matters, for the Autoimmune Association.
▶
1:29:13 Emergency Research Under Exception From Informed Consent
Neal W. Dickert, MD, PhD, and Carrie Sims, MD, PhD, with moderator William B. Feldman, MD, DPhil, discuss the ethics and law of emergency clinical research under waivers of informed consent, for the Harvard Medical School Center for Bioethics.
▶
4:57 Electronic Consent for Clinical Trials Using Blockchain
PharmaLedger describes use of a blockchain-based, unified platform for informed consent with the goal of enabling transparency among different members in the clinical trial ecosystem.
▶
15:45 CISCRP Discusses Clinical Trials Focusing on the Patient's Point of View
Clinical Trials vendor Curebase discusses modernization in clinical trials and then interviews a Lupus clinical trials participant who discusses her experiences about the trial including informed consent and travel.
▶
6:11 WhitehallTraining on Informed Consent Under ICH E6 (R3)
WhitehallTraining summarises the new informed consent requirements under ICH E6(R3) and what they mean for investigators, sponsors and research teams.
▶
59:05 The Ethics of Socioeconomic Opportunity in Research
A GW Public Health Bioethics Interest Group webinar examines the ethics of socioeconomic opportunity in research, including informed consent, privacy, and avoiding both excluding and overburdening vulnerable populations.